News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
548,391 Results
Type
Article (39885)
Company Profile (74)
Press Release (508432)
Multimedia
Podcasts (44)
Webinars (11)
Section
Business (152504)
Career Advice (2450)
Deals (27917)
Drug Delivery (99)
Drug Development (72854)
Employer Resources (142)
FDA (13631)
Job Trends (12220)
News (272159)
Policy (27120)
Tag
Academia (2541)
Academic (1)
Accelerated approval (5)
Adcomms (26)
Allergies (77)
Alliances (38475)
ALS (91)
Alzheimer's disease (1400)
Antibody-drug conjugate (ADC) (127)
Approvals (13624)
Artificial intelligence (239)
Autoimmune disease (23)
Automation (16)
Bankruptcy (311)
Best Places to Work (9969)
BIOSECURE Act (15)
Biosimilars (90)
Biotechnology (61)
Bladder cancer (80)
Brain cancer (26)
Breast cancer (264)
Cancer (2145)
Cardiovascular disease (185)
Career advice (2060)
Career pathing (33)
CAR-T (145)
Cell therapy (397)
Cervical cancer (16)
Clinical research (59462)
Collaboration (711)
Company closure (1)
Compensation (279)
Complete response letters (22)
COVID-19 (2466)
CRISPR (40)
C-suite (251)
Cystic fibrosis (82)
Data (2130)
Decentralized trials (2)
Denatured (7)
Depression (51)
Diabetes (254)
Diagnostics (5757)
Digital health (14)
Diversity (4)
Diversity, equity & inclusion (38)
Drug discovery (112)
Drug pricing (95)
Drug shortages (24)
Duchenne muscular dystrophy (89)
Earnings (55400)
Editorial (39)
Employer branding (19)
Employer resources (129)
Events (76542)
Executive appointments (718)
FDA (14784)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (658)
Gene editing (99)
Generative AI (20)
Gene therapy (301)
GLP-1 (698)
Government (4140)
Grass and pollen (5)
Guidances (65)
Healthcare (16113)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (128)
Indications (27)
Infectious disease (2608)
Inflammatory bowel disease (128)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (88)
Interviews (527)
IPO (12690)
IRA (42)
Job creations (2604)
Job search strategy (1683)
Kidney cancer (11)
Labor market (19)
Layoffs (419)
Leadership (24)
Legal (5791)
Liver cancer (71)
Lung cancer (321)
Lymphoma (146)
Machine learning (6)
Management (51)
Manufacturing (256)
MASH (74)
Medical device (10706)
Medtech (10710)
Mergers & acquisitions (15708)
Metabolic disorders (667)
Multiple sclerosis (77)
NASH (23)
Neurodegenerative disease (99)
Neuropsychiatric disorders (31)
Neuroscience (1943)
NextGen: Class of 2025 (5524)
Non-profit (3992)
Now hiring (31)
Obesity (348)
Opinion (218)
Ovarian cancer (71)
Pain (86)
Pancreatic cancer (79)
Parkinson's disease (144)
Partnered (17)
Patents (219)
Patient recruitment (107)
Peanut (40)
People (50746)
Pharmaceutical (22)
Pharmacy benefit managers (10)
Phase I (18296)
Phase II (26139)
Phase III (19978)
Pipeline (1156)
Policy (134)
Postmarket research (2314)
Preclinical (7497)
Press Release (61)
Prostate cancer (99)
Psychedelics (37)
Radiopharmaceuticals (214)
Rare diseases (360)
Real estate (4122)
Recruiting (56)
Regulatory (19182)
Reports (25)
Research institute (2118)
Resumes & cover letters (358)
Rett syndrome (5)
RNA editing (3)
RSV (39)
Schizophrenia (75)
Series A (117)
Series B (74)
Service/supplier (3)
Sickle cell disease (52)
Special edition (10)
Spinal muscular atrophy (145)
Sponsored (28)
Startups (2746)
State (2)
Stomach cancer (14)
Supply chain (57)
Tariffs (35)
The Weekly (36)
Vaccines (638)
Venture capitalists (31)
Weight loss (235)
Women's health (25)
Worklife (17)
Date
Today (60)
Last 7 days (760)
Last 30 days (2247)
Last 365 days (28559)
2025 (9369)
2024 (30702)
2023 (34520)
2022 (45064)
2021 (48409)
2020 (46745)
2019 (39825)
2018 (30160)
2017 (27061)
2016 (25768)
2015 (30118)
2014 (22591)
2013 (18334)
2012 (19592)
2011 (20620)
2010 (18223)
Location
Africa (726)
Alabama (48)
Alaska (5)
Arizona (143)
Arkansas (11)
Asia (34103)
Australia (7050)
California (5145)
Canada (1808)
China (468)
Colorado (225)
Connecticut (210)
Delaware (132)
Europe (75447)
Florida (818)
Georgia (168)
Idaho (49)
Illinois (453)
India (23)
Indiana (267)
Iowa (7)
Japan (151)
Kansas (88)
Kentucky (19)
Louisiana (9)
Maine (50)
Maryland (795)
Massachusetts (3602)
Michigan (193)
Minnesota (295)
Mississippi (1)
Missouri (75)
Montana (20)
Nebraska (22)
Nevada (56)
New Hampshire (63)
New Jersey (1517)
New Mexico (20)
New York (1486)
North Carolina (790)
North Dakota (5)
Northern California (2240)
Ohio (163)
Oklahoma (5)
Oregon (25)
Pennsylvania (1133)
Puerto Rico (12)
Rhode Island (27)
South America (995)
South Carolina (19)
South Dakota (1)
Southern California (1990)
Tennessee (81)
Texas (778)
United States (19268)
Utah (168)
Virginia (131)
Washington D.C. (50)
Washington State (470)
West Virginia (3)
Wisconsin (41)
548,391 Results for "reshape lifesciences formally known as enteromedics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
MASH
7 Late-Stage MASH Candidates That Could Reshape the Market
Akero Therapeutics, 89bio, Boston Pharmaceuticals and more are working to bring novel treatment options for metabolic dysfunction-associated steatohepatitis to a market that could reach $16 billion by 2033.
April 7, 2025
·
6 min read
·
Ben Hargreaves
IN PARTNERSHIP WITH DIA
Economic Challenges, Strategic Investments: Reshaping the Women’s Health Landscape
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses how collaboration and investment shape the the future of women’s health with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
April 24, 2025
·
1 min read
·
Lori Ellis
Press Releases
Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting
May 1, 2025
·
6 min read
Press Releases
ORYZON to Reshape Its Board of Directors at the Upcoming Shareholders’ Meeting
January 27, 2025
·
9 min read
Press Releases
Roquette Reshapes the Pharmaceutical Coating Landscape with an Innovative and High-Performance Platform
February 11, 2025
·
4 min read
Press Releases
Celltrion’s Remdantry™, previously known as Inflectra®, will be available in Canada as of April 1, 2025
March 27, 2025
·
3 min read
Press Releases
Know Labs Technology Licensing (KTL) Announces Formalized Client Engagement
February 6, 2025
·
7 min read
Press Releases
CB Scientific Inc. (CBSC) Formally Launches Next Generation MyCardia AT Cardiac Monitor
February 25, 2025
·
4 min read
Press Releases
Greenwich LifeSciences Provides Global Update on FLAMINGO-01
April 4, 2025
·
16 min read
Press Releases
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
January 28, 2025
·
4 min read
1 of 54,840
Next
